HEAR. HELP. HEAL. HOPE.
The ADAP Advocacy Association
mission is to promote and enhance the AIDS Drug Assistance Programs (ADAPs)
and improve access to care for persons living with HIV/AIDS.
works with advocates, community, health care, government, patients,
pharmaceutical companies and other stakeholders to assure that access to
services recognize and afford persons living with HIV/AIDS to enjoy a healthy
is the only national grassroots organization focused exclusively on ADAPs
and ensuring that there are adequate resources nationwide to eliminate or
prevent waiting lists for services. Our purpose is to better engage people
living with HIV/AIDS by providing a platform whereby they can offer their
personal experiences, challenges, knowledge, insight and solutions to solving
this perpetual problem.
ADAP Advocacy Association Releases 2014 Annual Report:
"Affordable Care Act implementation has not slowed down client enrollment
in ADAPs nationwide"
WASHINGTON, D.C. (July 28, 2015) The ADAP Advocacy Association, also
today released it 2014 Annual Report. Last year, relatively small waiting
lists returned under the AIDS Drug Assistance Programs (ADAPs), as client
enrollment has continued to expand despite implementation of the Affordable
Care Act (ACA), or Obamacare.
Its All About The Money: How Mandatory Mail Order Pharmacy
Puts The Lives of People Living With HIV and Hepatitis C At
By: Michelle J. Sherman, RPh, FASCP, AAHIVP, MichRx Pharmacist Consulting
Over the past couple of years health insurance companies have added HIV
antiretroviral medications to their Specialty Drug Lists. This
results in the drugs being placed on the highest copay tiers with the highest
copay structure. In many cases, it is unaffordable for people living with
HIV/AIDS. In addition, health insurers have forced clients to utilize mail
order Specialty Pharmacies picked by the health insurance plan.
What is Specialty Drug?
In defining specialty drugs there are two main factors: cost and complexity.
Using a cost-based approach, CMS [Centers for Medicare & Medicaid Services]
categorizes a specialty drug as one with a minimum monthly cost of $600 with
respect to the Medicare Part D drug benefit. Other organizations utilize
a higher cost threshold for specialty classification that may be as much
as double that of CMS. Complexity can encompass a number of factors and affect
various groups, including patients, payers, manufacturers, and the pharmacy
CLICK HERE to read more.
ADAPs with Waiting Lists
(35 individuals in 1 state(s) on the ADAP Waiting List as of
July 28, 2014)
Source: The ADAP Watch, National Alliance of State &
Territorial AIDS Directors (NASTAD).
Eleven ADAPs have had cost-containment measures in place since April 1, 2013
(reported as of July 15, 2014).
No ADAPs currently anticipate additional cost-containment measures prior
to March 31, 2015.
to the ADAP Watch